Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
7.81
+0.35 (4.69%)
At close: Sep 6, 2024, 4:00 PM
8.00
+0.19 (2.43%)
After-hours: Sep 6, 2024, 5:44 PM EDT
Terns Pharmaceuticals Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for TERN stock have an average target of 13.5, with a low estimate of 5.50 and a high estimate of 19. The average target predicts an increase of 72.86% from the current stock price of 7.81.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for TERN stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '24 | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 3 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 7 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +92.06% | Sep 3, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $19 | Buy | Reiterates | $19 | +143.28% | Aug 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | -29.58% | May 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +92.06% | Apr 30, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5.5 | Hold | Reiterates | $5.5 | -29.58% | Apr 30, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.39M
EPS This Year
-1.32
from -1.27
EPS Next Year
-1.40
from -1.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 12.3M | 16.0M | ||
| Avg | n/a | 2.4M | 5.2M | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | 568.6% | ||
| Avg | - | - | 116.5% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.26 | -1.06 | -0.91 | ||
| Avg | -1.32 | -1.40 | -1.27 | ||
| Low | -1.38 | -1.60 | -1.40 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.